CI vs RIGL · P/E 2.4, rev $274.90B vs P/E 9.1, rev $179.3M
Cigna Corp (CI) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
CI currently screens at market cap $71.62B and trailing P/E 2.4. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the CI and RIGL stock pages for the full models.
Not investment advice.